cirrhosis	is risk factor for	liver cancer
hepatitis B virus	is risk factor for	hepatocellular carcinoma
hepatitis C virus	is risk factor for	hepatocellular carcinoma
alcohol use	is risk factor for	liver cancer
nonalcoholic fatty liver disease	is risk factor for	liver cancer
diabetes mellitus	is risk factor for	hepatocellular carcinoma
obesity	is risk factor for	hepatocellular carcinoma
aflatoxin exposure	is risk factor for	hepatocellular carcinoma
age	is risk factor for	liver cancer
smoking	is risk factor for	liver cancer
primary sclerosing cholangitis	is risk factor for	intrahepatic cholangiocarcinoma
biliary cysts	is risk factor for	intrahepatic cholangiocarcinoma
age	is risk factor for	intrahepatic cholangiocarcinoma
alpha-fetoprotein	is biomarker for	hepatocellular carcinoma
CA 19-9	is biomarker for	intrahepatic cholangiocarcinoma
liver ultrasound	is screening method for	liver cancer
CT scan	is imaging modality for	liver cancer
MRI	is imaging modality for	liver cancer
PET-CT	is imaging modality for	metastatic liver cancer
biopsy	confirms	hepatocellular carcinoma
biopsy	confirms	intrahepatic cholangiocarcinoma
histology	defines	tumor type
vascular invasion	indicates	aggressive disease
tumor size	correlates with	prognosis
tumor stage	correlates with	prognosis
surgical resection	is curative for	hepatocellular carcinoma
hepatectomy	is treatment for	hepatocellular carcinoma
liver transplantation	can treat	hepatocellular carcinoma
transarterial chemoembolization	used for	hepatocellular carcinoma
radioembolization	used for	hepatocellular carcinoma
ablation	used for	hepatocellular carcinoma
radiation therapy	used for	hepatocellular carcinoma
atezolizumab	used for	hepatocellular carcinoma
bevacizumab	used with	atezolizumab
sorafenib	approved for	hepatocellular carcinoma
lenvatinib	approved for	hepatocellular carcinoma
regorafenib	approved for	hepatocellular carcinoma
pembrolizumab	used for	biliary tract cancer
nivolumab	used for	hepatocellular carcinoma
durvalumab	used for	biliary tract cancer
gemcitabine	used in	biliary tract cancer
cisplatin	used in	biliary tract cancer
gemcitabine	used with	cisplatin
cisplatin	combined with	gemcitabine
capecitabine	used in	biliary tract cancer
immunotherapy	used for	biliary tract cancer
liver-directed therapy	includes	TACE
transarterial chemoembolization	provides	local tumor necrosis
radioembolization	provides	local tumor control
ablation	provides	local tumor control
surgical margins	predict	recurrence
positive surgical margins	predict	recurrence
macrovascular invasion	indicates	advanced disease
portal vein thrombosis	complicates	liver cancer
ascites	accompanies	cirrhosis
hepatic encephalopathy	accompanies	liver cancer
Child-Pugh class	predicts	liver function
BCLC stage	guides	treatment strategy
TNM stage	informs	prognosis
recurrence	after resection	high
recurrence	after liver transplantation	variable
postoperative care	is necessary for	liver cancer surgery
surveillance imaging	detects	recurrence
surveillance biomarkers	monitor	disease status
alpha-fetoprotein level	tracks	hepatocellular carcinoma
CA 19-9 level	tracks	cholangiocarcinoma
liver function tests	reflect	liver function
bilirubin	reflects	cholestasis
albumin	reflects	synthetic liver function
portal hypertension	arises from	cirrhosis
ascites	accompanies	portal hypertension
hepatorenal syndrome	arises with	advanced liver cancer
malnutrition	worsens	prognosis
cachexia	worsens	prognosis
radiation therapy	provides	palliation
palliative care	improves	quality of life
smoking cessation	reduces	cancer risk
HBV vaccination	reduces	liver cancer risk
HCV treatment	reduces	hepatocellular carcinoma risk
liver cancer	has	mortality
hepatic failure	coexists with	liver cancer
hepatic encephalopathy	associated with	liver cancer
portal vein invasion	associated with	poor prognosis
biliary obstruction	occurs with	intrahepatic cholangiocarcinoma
jaundice	presents with	cholangiocarcinoma
weight loss	presents with	liver cancer
abdominal pain	presents with	liver cancer
fever	occurs with	cholangiocarcinoma
vascular thrombosis	coexists with	liver cancer
multidisciplinary care	requires	liver cancer
liver cancer surveillance	improves	early detection
tumor markers	monitor	disease status
HBV vaccination	reduces	cirrhosis progression
HCC screening	recommended for	cirrhosis patients
early-stage hepatocellular carcinoma	eligible for	surgical resection
late-stage hepatocellular carcinoma	requires	systemic therapy
gallbladder cancer	is different from	hepatocellular carcinoma
staging	informs	prognosis
staging	impacts	prognosis
treatment decision	depends on	tumor stage
